Dr. Brian Helfand

Brian Helfand, MD, PhD, is Chief of the Division of Urology and the Ronald L. Chez Family and Richard Melman Family Endowed Chair at NorthShore University HealthSystem. He is Director of the Personalized Prostate Program and Director of the Clinical Research Program. He is also an active surgeon who is involved in the care of this patients with prostate issues including benign prostatic hyperplasia. His clinical care and research programs are focused on implementation of personalized treatment plans that include providing therapies that are suited for their specific needs. As such, Dr. Helfand was an early adopter of Aquablation therapy to help relieve bothersome lower urinary tract symptoms for men with benign prostatic hyperplasia. Dr. Helfand completed his undergraduate degree at Emory University. He received his medical training and PhD in Cell and Molecular Biology and Genetics from Northwestern University. He is fellowhip trained in urologic oncology. He was recruited in 2011 from Northwestern University’s Feinberg School of Medicine, where he was faculty in the Department of Urology. Dr. Helfand is an internationally-recognized urologist and translational researcher. He has received multiple grants from the National Institute of Health and has published over 180 peer-reviewed manuscripts in prestigious journals including Nature Genetics, The Journal of Cell Biology, The Journal of Urology and Science Translational Medicine. Dr. Helfand is involved in national and international collaborative networks including the Lower Urinary Tract Dysfunction Network (LURN).